Capecitabine Plus Simvastatin in Locally Advanced Rectal Cancer Patients

Clinical trial NCT02161822 · UNKNOWN

Trial details

NCT number: NCT02161822
Sponsor: Samsung Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of Rectum

Start date: 2014-10-01
Primary completion: 2020-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.